Should You Buy Novo Nordisk Stock on Oral Wegovy's Strong Launch?

Should You Buy Novo Nordisk Stock on Oral Wegovy's Strong Launch?

This could finally be the start of the drugmaker's comeback.

Novo Nordisk Class B stock price: Wegovy pill scripts hit 26,000 as earnings week approaches

Copenhagen, Jan 31, 2026, 20:48 CET — The market has closed. Novo Nordisk’s Class B shares on the Copenhagen exchange slipped 0.23% to 369.55 Danish kroner Friday, marking roughly a 7.9% drop over the past five sessions. Investors now face a short weekend to process an expanding roster of catalysts. (MarketScreener) The stock’s immediate path depends on one key factor: can the new pill form of Wegovy actually expand the market for obesity drugs,…